Vivo Capital as of March 31, 2016
Portfolio Holdings for Vivo Capital
Vivo Capital holds 24 positions in its portfolio as reported in the March 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Aclaris Therapeutics (ACRS) | 19.9 | $79M | 4.2M | 18.95 | |
| Sagent Pharmaceuticals | 19.8 | $79M | 6.5M | 12.17 | |
| Biotie Therapies Corp. ads | 8.2 | $33M | 1.2M | 26.67 | |
| Nabriva Therapeutics | 7.1 | $28M | 3.2M | 8.96 | |
| Eiger Biopharmaceuticals | 6.7 | $27M | 1.6M | 16.77 | |
| Ascendis Pharma A S (ASND) | 6.6 | $26M | 1.4M | 18.55 | |
| Codexis (CDXS) | 4.3 | $17M | 5.6M | 3.11 | |
| Pronai Therapeutics | 4.1 | $16M | 2.4M | 6.74 | |
| Advanced Accelerat spon ads each rep 2 ord | 4.0 | $16M | 456k | 35.02 | |
| Agile Therapeutics | 3.1 | $13M | 2.0M | 6.21 | |
| Regenxbio Inc equity us cm (RGNX) | 2.7 | $11M | 990k | 10.80 | |
| Trevena | 2.5 | $9.9M | 1.2M | 8.27 | |
| Capnia | 2.2 | $8.9M | 7.5M | 1.19 | |
| Kite Pharma | 2.2 | $8.9M | 193k | 45.91 | |
| Akari Therapeutics | 1.9 | $7.4M | 528k | 14.00 | |
| Dynavax Technologies (DVAX) | 1.7 | $6.9M | 358k | 19.24 | |
| Mei Pharma | 0.9 | $3.5M | 2.8M | 1.26 | |
| Carbylan Therapeutics Inc Common Stock Usd 0.001 | 0.7 | $2.7M | 4.2M | 0.64 | |
| Chemocentryx | 0.6 | $2.2M | 888k | 2.49 | |
| Revance Therapeutics | 0.5 | $1.9M | 77k | 24.38 | |
| Ocera Therapeutics | 0.1 | $451k | 153k | 2.94 | |
| Zosano Pharma | 0.1 | $227k | 99k | 2.30 | |
| Capnia Inc Common Stock Warrants | 0.1 | $215k | 933k | 0.23 | |
| Palatin Technologies | 0.0 | $127k | 235k | 0.54 |
